Related Experiment Video
Updated: Jun 14, 2025

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
Published on: October 17, 2015
Amyloid precursor protein carboxy-terminal fragments as catalyzers of endolysosomal dysfunction in Alzheimer's
1Laboratory for Membrane Trafficking, VIB Center for Brain and Disease Research, Leuven, Belgium; Department of Neurosciences, KU Leuven, Leuven, Belgium.
Abstract:
Proteolytic processing of the amyloid precursor protein (APP) generates not only the well-known β-amyloid (Aβ) peptides but also APP C-terminal fragments (APP-CTFs). Recent evidence from studies in murine- or human-derived (neuronal) models suggests that APP-CTFs may independently contribute to Alzheimer's disease (AD) pathology by disrupting cellular homeostasis. This review highlights pathological effects unique to APP-CTFs that are independent of Aβ, shedding light on their distinct role in disease progression. We explore the mechanisms underlying APP-CTF-induced toxicity, with a focus on their contribution to endolysosomal dysfunction. APP-CTFs impair lysosomal function and disrupt calcium signaling between the endoplasmic reticulum and lysosomes, compounding organelle dysfunction. Understanding these mechanisms will aid the design of preventive therapeutic strategies that take into account the impact of APP-CTFs on AD pathology.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Lysosomal Hydrolases
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The Early Endosome: Endocytosis of Transferrin
Export of Misfolded Proteins out of the ER
Mitochondrial Precursor Proteins
Most of the mitochondrial...

